Related Experiment Video
Updated: Jun 23, 2026

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
Thrombolysis: adjuvant therapy and the role of complement
1Cardiovascular Research Unit, Edinburgh, U.K.
Insights
Adjuvant therapy after thrombolysis may reduce myocardial stunning and necrosis by preventing reperfusion injury. Understanding injury mechanisms, including complement
Area of Science:
- Cardiovascular Medicine
- Ischemia-Reperfusion Biology
Background:
- Thrombolysis for myocardial infarction can lead to reperfusion injury, causing 'stunned myocardium' and potentially necrosis.
- The extent of myocardial damage after ischemia and reperfusion is not fully understood.
- Mechanisms of injury and repair, particularly the role of complement, are key to understanding myocardial stunning.
Purpose of the Study:
- To investigate the potential role of adjuvant therapy in mitigating reperfusion injury following thrombolysis.
- To determine if preventing reperfusion injury can reduce myocardial stunning and necrosis.
- To explore whether modifying reperfusion injury favorably impacts clinical outcomes.
Main Methods:
- Review of existing literature on ischemia-reperfusion injury and myocardial stunning.
- Identification of key mediators involved in myocardial damage and repair.
- Analysis of the role of complement in the context of coronary artery thrombus lysis and reperfusion.
Main Results:
- Reperfusion injury and stunned myocardium are significant concerns after thrombolysis.
- Complement activation plays a central role in the inflammatory response to reperfusion.
- Interventions targeting reperfusion injury mechanisms are being explored.
Conclusions:
- Adjuvant therapy following thrombolysis holds potential for reducing myocardial stunning and necrosis.
- A deeper understanding of ischemia-reperfusion mechanisms is essential for developing effective interventions.
- Further research is needed to confirm the clinical benefits of modifying reperfusion injury.
Abstract:
A possible role for adjuvant therapy following thrombolysis exists in the context of reperfusion injury and post-ischaemic dysfunction, or so-called 'stunned myocardium'. The question that arises is whether the extent of myocardial stunning, or the ultimate extent of necrosis, can be reduced by preventing reperfusion injury and the impairment of reflow. Essential to any attempted intervention is an understanding of the mechanisms underlying myocardial damage following ischaemia and reperfusion. Certain mediators responsible for injury and repair have been identified, and their effects modified in experimental preparations; the role of complement, in particular, is central to these phenomena. Lysis of coronary artery thrombus is only the initiator of a sequence of events involving vascular endothelium and an intravascular response to tissue injury. The challenge is whether reperfusion injury may be modified and whether such intervention will favourably alter clinical outcome.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Clot Retraction and Fibrinolysis
Complement System
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

